Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gent

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Chemosphere|April 10, 2010
Desorption behavior of carbon tetrachloride and chloroform in contaminated low organic carbon aquifer sedimentsRobert G Riley, James E Szecsody, Debbie S Sklarew, et al.
The Canadian Journal of Cardiology|June 1, 1989
One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 peopleJ A Cairns, J Singer, M Gent, et al.
Circulation|October 3, 2001
Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator studyR Sheldon, B J O'Brien, G Blackhouse, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
The New England Journal of Medicine|March 14, 1996
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosisM Levine, M Gent, J Hirsh, et al.
The Canadian Journal of Cardiology|January 1, 1988
Coronary care unit utilization in Hamilton, Ontario, a city of 375,000 peopleJ A Cairns, J Singer, M Gent, et al.
Diabetes Care|November 1, 1988
Clinical trials of cyclosporin in IDDMJ Dupré, C R Stiller, M Gent, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Annals of Internal Medicine|October 6, 1997
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trialK S Robinson, D R Anderson, M Gross, et al.
Archives of Internal Medicine|October 8, 1999
Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin timesS S Anand, S Bates, J S Ginsberg, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Chemosphere|April 10, 2010
Desorption behavior of carbon tetrachloride and chloroform in contaminated low organic carbon aquifer sedimentsRobert G Riley, James E Szecsody, Debbie S Sklarew, et al.
The Canadian Journal of Cardiology|June 1, 1989
One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 peopleJ A Cairns, J Singer, M Gent, et al.
Circulation|October 3, 2001
Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator studyR Sheldon, B J O'Brien, G Blackhouse, et al.
Lancet (London, England)|April 9, 1994
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerM Levine, J Hirsh, M Gent, et al.
The New England Journal of Medicine|March 14, 1996
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosisM Levine, M Gent, J Hirsh, et al.
The Canadian Journal of Cardiology|January 1, 1988
Coronary care unit utilization in Hamilton, Ontario, a city of 375,000 peopleJ A Cairns, J Singer, M Gent, et al.
Diabetes Care|November 1, 1988
Clinical trials of cyclosporin in IDDMJ Dupré, C R Stiller, M Gent, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Annals of Internal Medicine|October 6, 1997
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trialK S Robinson, D R Anderson, M Gross, et al.
Archives of Internal Medicine|October 8, 1999
Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin timesS S Anand, S Bates, J S Ginsberg, et al.
Pageof 25